Forbes: Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Drugmakers Novo Nordisk And Eli Lilly Anytime Soon
Additional Content
Fox Business: Southwest Airlines risks losing customers over new bag policy, expert says
The Telegraph: Elon Musk is destroying Tesla. Not even Donald Trump can save it
Forbes: Volkswagen Expects Solid Profits Despite EuropeTariff Challenges
CNBC: Adidas’ fourth-quarter sales top expectations as final Yeezy stock sold off
Reuters: Nvidia: AI boom not dead yet
Barron’s:Snowflake Posts a Big Earnings Beat. The Stock Jumps.
The New York Times: Russia Is Wooing Western Energy Companies, but Will They Return?
Yahoo Finance: Meta: Are humanoid robots reshaping the tech giant’s AI narrative?
